Literature DB >> 23318130

Modulation of central nervous system-specific microRNA-124a alters the inflammatory response in the formalin test in mice.

Katharina L Kynast1, Otto Quintus Russe, Christine V Möser, Gerd Geisslinger, Ellen Niederberger.   

Abstract

microRNAs (miRNAs) are small noncoding RNAs that have been linked to a number of disease-related signal transduction pathways. Several studies indicate that they are also involved in nociception. It is not clear, however, which miRNAs are important and which genes are modulated by miRNA-associated mechanisms. This study focuses on the regulation and function of the central nervous system (CNS)-specific miRNA-124a in the spinal cord of mice in a formalin model of inflammatory nociception. miRNA-124a is constitutively expressed in the spinal cord of mice, particularly in neurons of the dorsal horn. Peripheral noxious stimulation with formalin led to significant down-regulation of its expression. Knock-down of miRNA-124a by intravenous administration of a specific miRNA-124a inhibitor further increased the nociceptive behavior associated with an upregulation of the pain-relevant miRNA-124a target MeCP2 and proinflammatory marker genes. In contrast, administration of a miRNA-124a mimic counteracted these effects and decreased nociception by down-regulation of the target gene. In conclusion, our results indicate that miRNA-124a is involved in inflammatory nociception by regulation of relevant target proteins and might therefore constitute a novel target for anti-inflammatory therapy.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23318130     DOI: 10.1016/j.pain.2012.11.010

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  32 in total

1.  Computational functional genomics based analysis of pain-relevant micro-RNAs.

Authors:  Jörn Lötsch; Ellen Niederberger; Alfred Ultsch
Journal:  Hum Genet       Date:  2015-09-18       Impact factor: 4.132

Review 2.  [Pharmacological aspects of pain research in Germany].

Authors:  E Niederberger; R Kuner; G Geißlinger
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

Review 3.  [Epigenetics and pain].

Authors:  E Niederberger
Journal:  Anaesthesist       Date:  2014-01       Impact factor: 1.041

Review 4.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

5.  Vitamin D Deficiency and Molecular Changes in Circulating MicroRNAs in Older Adults with Lower Back Pain.

Authors:  Hadeel A Al-Rawaf; Sami A Gabr; Ahmad H Alghadir
Journal:  Pain Res Manag       Date:  2021-05-17       Impact factor: 3.037

6.  MicroRNA-124 and microRNA-146a both attenuate persistent neuropathic pain induced by morphine in male rats.

Authors:  Peter M Grace; Keith A Strand; Erika L Galer; Steven F Maier; Linda R Watkins
Journal:  Brain Res       Date:  2018-05-01       Impact factor: 3.252

Review 7.  Epigenetic mechanisms of chronic pain.

Authors:  Giannina Descalzi; Daigo Ikegami; Toshikazu Ushijima; Eric J Nestler; Venetia Zachariou; Minoru Narita
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

8.  Whiplash-Associated Dysphagia: Considerations of Potential Incidence and Mechanisms.

Authors:  D Stone; H Bogaardt; S D Linnstaedt; B Martin-Harris; A C Smith; D M Walton; E Ward; J M Elliott
Journal:  Dysphagia       Date:  2019-08-03       Impact factor: 3.438

9.  MeCP2 repression of G9a in regulation of pain and morphine reward.

Authors:  Zhi Zhang; Wenjuan Tao; Yuan-Yuan Hou; Wei Wang; Paul J Kenny; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2014-07-02       Impact factor: 6.167

Review 10.  Non-coding RNAs as Emerging Regulators of Neural Injury Responses and Regeneration.

Authors:  Songlin Zhou; Fei Ding; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2016-04-01       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.